Major depression is a serious and potentially fatal brain syndrome requiring pharmacotherapy or neuromodulation, and psychotherapy

Depression: why drugs and electricity are not the answer

(2022) John Read et al.   PSYCHOLOGICAL MEDICINE

Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

(2021) Tyra Lagerberg et al.   NEUROPSYCHOPHARMACOLOGY

Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder

(2020) Kevin M. Anderson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study

(2019) Bernhard M. Meyer et al.   Translational Psychiatry

Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed

(2016) Leslie Citrome   JOURNAL OF AFFECTIVE DISORDERS

How effective are common medications: a perspective based on meta-analyses of major drugs

(2015) Stefan Leucht et al.   BMC Medicine

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder

(2012) Hyo Jung Kang et al.   NATURE MEDICINE

A Molecular Signature of Depression in the Amygdala

(2009) Etienne Sibille et al.   AMERICAN JOURNAL OF PSYCHIATRY